STOCK TITAN

Aberdeen Group files 13G for 4.2M Codexis shares, hitting 5% threshold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Aberdeen Group plc and its U.S. affiliate abrdn Inc. jointly filed a Schedule 13G reporting passive ownership of 4,200,950 Codexis (CDXS) common shares as of 30 Jun 2025. The position equals 5.07 % of outstanding stock, making the firms a 5-percent beneficial owner under SEC rules.

The filing states shared voting and dispositive power over the entire stake; neither entity holds sole authority. Aberdeen is classified as a parent holding company/control person (HC) incorporated in the United Kingdom, while abrdn Inc. is a U.S. corporation and registered investment adviser (CO, IA). Both certify the shares were acquired in the ordinary course of business and not to influence control of Codexis.

Signatures were provided by Major Shareholding Reporting Analyst Jenny Clarke on 30 Jul 2025. No exhibits indicate activist intent, group formation, or additional derivatives. The disclosure primarily informs investors of a new institutional holder exceeding the 5 % threshold, adding visibility to Codexis’ shareholder base without signaling governance changes.

Positive

  • abrdn/Aberdeen disclose a 5.07 % passive stake, adding a well-known institutional investor to Codexis’ shareholder base and potentially supporting stock liquidity.

Negative

  • None.

Insights

TL;DR: abrdn now owns 5.07 % of CDXS; passive stake raises institutional profile but offers limited strategic influence.

This Schedule 13G is informational rather than catalytic. abrdn’s 4.2 M-share position makes it a top holder for a sub-$1 bn market-cap company, potentially improving liquidity and signaling confidence in Codexis’ prospects. However, the lack of sole voting power and the Rule 13d-1(b) passive filing status suggest no immediate push for operational or governance changes. The impact on valuation depends on whether other institutions follow; as it stands, it modestly broadens institutional ownership without affecting control dynamics or capital structure.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Aberdeen Group plc
Signature:Jenny Clarke
Name/Title:Major Shareholding Reporting Analyst
Date:07/30/2025
abrdn Inc.
Signature:Jenny Clarke
Name/Title:Major Shareholding Reporting Analyst
Date:07/30/2025
Exhibit Information

Aberdeen Group plc abrdn Holdings Limited abrdn Inc. Aberdeen Group plc is the parent company. abrdn Holdings Limited is the intermediate holding company for abrdn Inc. abrdn Inc. beneficially owns on behalf of our underlying clients 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.

FAQ

How many Codexis (CDXS) shares does abrdn Inc. own?

4,200,950 shares, representing 5.07 % of outstanding common stock.

Is the abrdn stake in Codexis considered active or passive?

The Schedule 13G was filed under Rule 13d-1(b), indicating a passive investment with no intent to influence control.

Does abrdn Inc. have sole voting rights over its Codexis shares?

No. The filing lists 0 shares with sole voting power; all 4.2 M shares are held with shared voting and dispositive power.

What type of reporting persons are Aberdeen Group plc and abrdn Inc.?

Aberdeen Group plc is a parent holding company/control person (HC); abrdn Inc. is a corporation and registered investment adviser (CO, IA).

When was the ownership position effective?

The date of event triggering the filing is 06 / 30 / 2025.
Codexis Inc

NASDAQ:CDXS

View CDXS Stock Overview

CDXS Rankings

CDXS Latest News

CDXS Latest SEC Filings

CDXS Stock Data

133.58M
87.74M
Biotechnology
Industrial Organic Chemicals
Link
United States
REDWOOD CITY